Business Context and Reporting Period
This Form 8-K filing by BlueLinx Holdings Inc. covers events occurring on January 26, 2016, and February 1, 2016. The report addresses a regulatory notice regarding the company's continued listing status on the New York Stock Exchange (NYSE) and the disclosure of a real estate mortgage extension term sheet.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin figures. However, it discloses the following financial thresholds that triggered the listing notice:
- Market Capitalization: The average global market capitalization over a consecutive 30 trading-day period was less than $50 million.
- Stockholders' Equity: Stockholders' equity was less than $50 million.
Material Changes
The primary material change is the receipt of a notice from the NYSE on January 26, 2016, stating that the Company was not in compliance with Section 802.01B of the NYSE Listed Company Manual as of January 19, 2016. This noncompliance is due to the failure to meet the minimum market capitalization and stockholders' equity standards simultaneously.
Outlook, Management Commentary, and Risks
Remediation Plan: The Company intends to submit a plan to the NYSE on or before February 9, 2016, to cure the deficiency. Under NYSE rules, the Company has 45 days to submit a plan demonstrating definitive actions to conform to market capitalization standards within 18 months.
Listing Status: The notice has no immediate impact on the listing; the common stock will continue to be listed and traded on the NYSE during the cure period, subject to compliance with other standards and quarterly monitoring.
Additional Disclosure: The Company also disclosed a real estate mortgage extension term sheet, though specific terms were not detailed in the filing text.
Investor Verification Checklist
- Verify the specific details of the real estate mortgage extension term sheet referenced in the press release (Exhibit 99.1).
- Monitor the submission of the compliance plan to the NYSE by February 9, 2016.
- Track the Company's progress in meeting the 18-month cure period requirements for market capitalization.
- Review subsequent quarterly reports for updates on stockholders' equity and market capitalization trends.